We have found 801 companies that use Illumina DNA Sequencing. Our data for Illumina DNA Sequencing usage goes back as far as 1 years and 9 months.
|THE BROAD INSTITUTE, INC.||broadinstitute.org||2017-09-20|
|Baylor College of Medicine||bcm.edu||2017-09-20|
We use the best scanning techniques combined with advanced data science to monitor the market share of over 5,000 technology products, including Healthcare. In the Healthcare category, Illumina DNA Sequencing has a market share of about 1.3%. Other major and competing products in this category include:
For DNA sequencing, Illumina's next-generation sequencing (NGS) technology uses clonal amplification and sequencing by synthesis (SBS) chemistry to enable rapid, accurate sequencing. The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain.
Looking at Illumina DNA Sequencing customers by industry, we find that Higher Education (26%), Hospital & Health Care (21%), Biotechnology (10%) and Research (7%) are the largest segments.
|Industry||Number of companies|
|Hospital & Health Care||183|
|Staffing and Recruiting||12|
57% of Illumina DNA Sequencing customers are in United States and 6% are in United Kingdom.
|Country||Number of companies|
|Employees||Number of companies|
|Revenue (in USD)||Number of companies|